Previous reports suggested that the inhibition of expression of PKM2 affects cell proliferation and invasion of tumors, and induces cell apoptosis, and inhibits cell growth of tumors in animal models of tumors, including breast cancer, myeloma, prostate cancer, liver cancer, pancreatic cancer and lung cancer [16–19]. This evidence concerns the gene PKM and prostate carcinoma.